Tong Su

832 total citations
63 papers, 569 citations indexed

About

Tong Su is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Tong Su has authored 63 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Tong Su's work include RNA modifications and cancer (12 papers), Oral Health Pathology and Treatment (9 papers) and Advancements in Battery Materials (8 papers). Tong Su is often cited by papers focused on RNA modifications and cancer (12 papers), Oral Health Pathology and Treatment (9 papers) and Advancements in Battery Materials (8 papers). Tong Su collaborates with scholars based in China, United States and Denmark. Tong Su's co-authors include Haofeng Xiong, Kun Xia, Xin Hu, M. Morgan Taylor, Jennifer L. Quon, David M. Feliciano, Angélique Bordey, Canhua Jiang, Shichun Zhang and Anjie Min and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Power Sources.

In The Last Decade

Tong Su

58 papers receiving 566 citations

Peers

Tong Su
Comparison fields: 5 of 83
  • Molecular Biology 240
  • Oncology 115
  • Cancer Research 106
  • Surgery 91
  • Pulmonary and Respiratory Medicine 66
Replace Xin Xia with:
Xin Xia China
Zhongming Lu China
Qi Niu China
Yong Wen China
Xingying Qi China
Zhanchun Li China
Alex P. Rickel United States
Reinier Bron Netherlands
Qinglai Tang China
Siqi Zhang China
Xin Xia China View profile →
Citations per field, relative to Tong Su
Tong Su · 1×
Citations per year, relative to Tong Su
Tong Su · 1×

Countries citing papers authored by Tong Su

Since Specialization
Citations

This map shows the geographic impact of Tong Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tong Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tong Su more than expected).

Fields of papers citing papers by Tong Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tong Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tong Su. The network helps show where Tong Su may publish in the future.

Co-authorship network of co-authors of Tong Su

This figure shows the co-authorship network connecting the top 25 collaborators of Tong Su. A scholar is included among the top collaborators of Tong Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tong Su. Tong Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 0
3 5
4 8
5 1
6 1
7 3
8 1
9 12
10 20
11 5
12 3
13
Tumor-Infiltrating CD4+ Central Memory T Cells Correlated with Favorable Prognosis in Oral Squamous Cell Carcinoma
17
14 14
15 16
16 3
17 4
18 6
19 8
20 25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026